These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 11738720)
21. Isolation and characterization of hirudin isoinhibitors and sequence analysis of hirudin PA. Dodt J; Machleidt W; Seemüller U; Maschler R; Fritz H Biol Chem Hoppe Seyler; 1986 Aug; 367(8):803-11. PubMed ID: 3768144 [TBL] [Abstract][Full Text] [Related]
22. Deciphering the structural elements of hirudin C-terminal peptide that bind to the fibrinogen recognition site of alpha-thrombin. Chang JY Biochemistry; 1991 Jul; 30(27):6656-61. PubMed ID: 2065053 [TBL] [Abstract][Full Text] [Related]
23. Recombinant hirudin: kinetic mechanism for the inhibition of human thrombin. Stone SR; Hofsteenge J Protein Eng; 1991 Feb; 4(3):295-300. PubMed ID: 1857714 [TBL] [Abstract][Full Text] [Related]
24. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation. De Filippis V; Colombo G; Russo I; Spadari B; Fontana A Biochemistry; 2002 Nov; 41(46):13556-69. PubMed ID: 12427016 [TBL] [Abstract][Full Text] [Related]
25. An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agent. Fareed J; Walenga JM; Iyer L; Hoppensteadt D; Pifarre R Blood Coagul Fibrinolysis; 1991 Feb; 2(1):135-47. PubMed ID: 1772981 [TBL] [Abstract][Full Text] [Related]
26. Novel method of expression and purification of hirudin based on pBAD TOPO, pTYB12 vectors and gene synthesis. Kochanowski R; Kotłowski R; Szweda P Protein Expr Purif; 2006 Nov; 50(1):25-30. PubMed ID: 16857385 [TBL] [Abstract][Full Text] [Related]
27. Determination of recombinant hirudin structural deviants by capillary zone electrophoresis augmented with buffer additives. Dönges R; Brazel D J Chromatogr A; 2002 Dec; 979(1-2):217-26. PubMed ID: 12498251 [TBL] [Abstract][Full Text] [Related]
28. [Biotechnological production of recombinant analogs of hirudin-1 from Hirudo medicinalis]. Kostromina MA; Esipov RS; Miroshnikov AI Bioorg Khim; 2012; 38(2):166-76. PubMed ID: 22792720 [TBL] [Abstract][Full Text] [Related]
30. Rapid purification and revised amino-terminal sequence of hirudin: a specific thrombin inhibitor of the bloodsucking leech. Mao SJ; Yates MT; Blankenship DT; Cardin AD; Krstenansky JL; Lovenberg W; Jackson RL Anal Biochem; 1987 Mar; 161(2):514-8. PubMed ID: 3578808 [TBL] [Abstract][Full Text] [Related]
31. Purification and identification of recombinant hirudin and its degradation products expressed in Pichia pastoris. Zhou WB; Zhang YX Prep Biochem Biotechnol; 2004 Aug; 34(3):239-52. PubMed ID: 15461140 [TBL] [Abstract][Full Text] [Related]
32. Incorporation of norleucine at methionine positions in recombinant human macrophage colony stimulating factor (M-CSF, 4-153) expressed in Escherichia coli: structural analysis. Randhawa ZI; Witkowska HE; Cone J; Wilkins JA; Hughes P; Yamanishi K; Yasuda S; Masui Y; Arthur P; Kletke C Biochemistry; 1994 Apr; 33(14):4352-62. PubMed ID: 8155653 [TBL] [Abstract][Full Text] [Related]
33. Anti-hirudin monoclonal antibodies directed toward discontinuous epitopes of the hirudin amino-terminal and epitopes involving the carboxy-terminal hirudin amino acids. Koch C; Whitechurch O; Cordier P; Roitsch C Anal Biochem; 1993 Oct; 214(1):301-12. PubMed ID: 7504411 [TBL] [Abstract][Full Text] [Related]
34. Stereoselective incorporation of an unsaturated isoleucine analogue into a protein expressed in E. coli. Mock ML; Michon T; van Hest JC; Tirrell DA Chembiochem; 2006 Jan; 7(1):83-7. PubMed ID: 16397872 [TBL] [Abstract][Full Text] [Related]
35. Optimization of expression of an annexin V-hirudin chimeric protein in Escherichia coli. Yuan H; Yang X; Hua ZC Microbiol Res; 2004; 159(2):147-56. PubMed ID: 15293949 [TBL] [Abstract][Full Text] [Related]
36. Synthesis and characterization of more potent analogues of hirudin fragment 1-47 containing non-natural amino acids. De Filippis V; Quarzago D; Vindigni A; Di Cera E; Fontana A Biochemistry; 1998 Sep; 37(39):13507-15. PubMed ID: 9753436 [TBL] [Abstract][Full Text] [Related]
37. Functional properties of a recombinant chimeric protein with combined thrombin inhibitory and plasminogen-activating potential. Lijnen HR; Wnendt S; Schneider J; Janocha E; Van Hoef B; Collen D; Steffens GJ Eur J Biochem; 1995 Nov; 234(1):350-7. PubMed ID: 8529664 [TBL] [Abstract][Full Text] [Related]
38. Isolation of Escherichia coli synthesized recombinant eukaryotic proteins that contain epsilon-N-acetyllysine. Violand BN; Schlittler MR; Lawson CQ; Kane JF; Siegel NR; Smith CE; Kolodziej EW; Duffin KL Protein Sci; 1994 Jul; 3(7):1089-97. PubMed ID: 7920255 [TBL] [Abstract][Full Text] [Related]
39. Construction and characterization of a novel staphylokinase variant with thrombin-inhibitory activity. Wang M; Wang Y; Wang J; Zou M; Liu S; Xu T; Cai X; Wu C; Wang J; Xu D Biotechnol Lett; 2009 Dec; 31(12):1923-7. PubMed ID: 19685208 [TBL] [Abstract][Full Text] [Related]
40. Conformational stability of a thrombin-binding peptide derived from the hirudin C-terminus. Ni F; Ripoll DR; Purisima EO Biochemistry; 1992 Mar; 31(9):2545-54. PubMed ID: 1547237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]